b-TrCP, the substrate recognition subunit of a Skp1-Cul1-F-box (SCF) ubiquitin ligase, is ubiquitously expressed from two distinct paralogs, targeting many regulatory proteins for proteasomal degradation. We generated inducible b-TrCP hypomorphic mice and found that they are surprisingly healthy, yet have a severe testicular defect. We show that the two b-TrCP paralogs have a nonredundant role in spermatogenesis. The testicular defect is tightly associated with cell adhesion failure within the seminiferous tubules and is fully reversible upon b-TrCP restoration. Remarkably, testicular depletion of a single b-TrCP substrate, Snail1, rescued the adhesion defect and restored spermatogenesis. Our studies highlight an unexpected functional reserve of this central E3, as well as a bottleneck in a specific tissue: a single substrate whose stabilization is incompatible with testicular differentiation.
b-TrCP, the substrate recognition subunit of a Skp1-Cul1-F-box (SCF) ubiquitin ligase, is ubiquitously expressed from two distinct paralogs, targeting many regulatory proteins for proteasomal degradation. We generated inducible b-TrCP hypomorphic mice and found that they are surprisingly healthy, yet have a severe testicular defect. We show that the two b-TrCP paralogs have a nonredundant role in spermatogenesis. The testicular defect is tightly associated with cell adhesion failure within the seminiferous tubules and is fully reversible upon b-TrCP restoration. Remarkably, testicular depletion of a single b-TrCP substrate, Snail1, rescued the adhesion defect and restored spermatogenesis. Our studies highlight an unexpected functional reserve of this central E3, as well as a bottleneck in a specific tissue: a single substrate whose stabilization is incompatible with testicular differentiation.
[Keywords: shRNA transgenic mouse; SCF-E3; b-TrCP paralogs; adherens junctions; Snail1; spermatogenesis] Supplemental material is available at http://www.genesdev.org. One of the highly studied and best characterized E3 ubiquitin ligases is b-TrCP (Fuchs et al. 2004; Nakayama and Nakayama 2006; Frescas and Pagano 2008) . Mammals express two distinct paralogs of b-TrCP-BTRC and Fbxw11 (also known as b-TrCP1 and b-TrCP2)-with biochemical properties that are indistinguishable (Suzuki et al. 1999; Tan et al. 1999) . b-TrCP is expressed ubiquitously, but more so in various types of human cancer (Fuchs et al. 2004) , particularly in the gastrointestinal tract (Saitoh and Katoh 2001) . Many of the b-TrCP targets are cell cycle and apoptotic regulators, explaining why RNAi and forced expression of a dominant-negative b-TrCP mutant induce apoptosis in human malignant melanoma (Soldatenkov et al. 1999 ) and breast cancer (Kudo et al. 2004; Bhatia et al. 2008) and augment the cytotoxic effects of anti-cancer drugs and ionizing radiation (Tang et al. 2005) . Collectively, this knowledge justifies considering b-TrCP as a potential target in cancer therapy, but falls short of indicating the safety of systemic inhibition. The latter could be inferred from gene ablation studies in model animals, yet is often hindered by their limitations: genetic redundancy on the one hand, and the possible lethal effects of gene ablation in a tissue or the entire organism on the other hand.
Male b-TrCP1 (BTRC)-deficient mice have moderate impairment in spermatogenesis and reduced fertility without other signs of gross tissue abnormalities and illness, probably due to the compensatory effect of b-TrCP2 (Fbxw11) (Guardavaccaro et al. 2003) . This apparent redundancy of the two b-TrCP paralogs poses a question: What is the functional advantage of this redundancy, particularly considering the evolutionary conservation of the two paralogs (Ihmels et al. 2007 )? Functional redundancy due to gene duplications is a characteristic feature of many biological systems, most often recurring within a signaling, developmental, or metabolic context (Kafri et al. 2009 ). Nevertheless, the impact of this redundancy has seldom been explored in mammalians. To gain an understanding of b-TrCP redundancy, we generated a mouse strain carrying an inducible shb-TrCP2 transgene and crossed it to the b-TrCP1 knockout mouse. This conditionally double-deficient mouse was investigated in comparison with its parental strains-b-TrCP1 À/À and the shb-TrCP2 transgenic mouse-with the purpose of assessing overlapping functions of the two b-TrCP paralogs in different mouse tissues. Furthermore, by achieving transient, significant, yet incomplete ablation of b-TrCP2, we created a mouse model that overcomes the limitation of traditional conditional ablation studies. Our b-TrCP2 ablation protocol on a b-TrCP1-null background simulates a drug inhibitory effect, and may therefore predict tissue-specific effects and systemic tolerance to b-TrCPbased therapeutic intervention.
Results

Mice deficient in both b-TrCP isoforms have a severe testicular phenotype
The shb-TrCP2 transgene is induced by tetracycline treatment (Fig. 1A) , causing a variable reduction of b-TrCP2 mRNA in different tissues ranging from 60% to 90% (Supplemental Fig. S1C ). Mouse embryonic fibroblasts (MEFs) derived from the hybrid strain (shb-TrCP2 transgenic mice crossed with b-TrCP1 knockout mice, denoted KO1/KD2) had 15%-20% residual b-TrCP2 mRNA levels upon doxycycline treatment. These MEFs had stabilized phosphorylated b-catenin and IkBa levels following TNFa treatment. shb-TrCP2 (KD2) alone, and particularly in combination with a single allelic loss of b-TrCP1, led to intermediate substrate stabilization, whereas MEFs from b-TrCP1 knockout (KO1) were comparable with wild type (Supplemental Fig. S1B ). Surprisingly, there were no signs of illness or malfunction in tetracycline-treated mice observed for many weeks, nor did we detect gross tissue abnormalities in the induced hybrid mice, even at tissues with residual b-TrCP2 expression of 10%-all with the exception of the testis ( Fig. 1C; Supplemental Fig. S1C ). Four weeks following the initiation of tetracycline treatment, the hybrid testes (KO1/KD2) (n = 32) were much smaller than those of control heterozygous, KO1 (n = 8), or KD2 mice (n = 29) (Fig. 1B) . Whereas the KD2 testes resembled wild-type mice histologically, KO1/KD2 testes show disordered tissue architecture and lack of mieotic cells, spermatids, and sperm with 100% penetrance. The lumen of the KO1/KD2 seminiferous tubules is occupied by cells with homogeneously distributed chromatin (Fig. 1D , top panel; Supplemental Fig. S1D ), suggesting that they are dislocated spermatogonial stem cells (Dettin et al. 2003) . We verified the identity of these cells by immunostaining for a mitosis marker (phospho-Histone H3) (Fig. 1D , middle panel) and a specific type A spermatogonial cell marker, Oct3/4 (Fig. 1D , bottom panel; Gidekel et al. 2003) . The ectopic localization of the type A spermatogonial cells and the deformation of the seminiferous tubules could indicate an impairment in cell-cell interaction that is needed for spermatogenesis (Xia et al. 2005a; Oatley and Brinster 2008) .
A nonredundant role of the b-TrCP isoforms in the spermatogenesis process
The phenotype observed in KO1/KD2 testes is distinct from the one associated with KO1 alone, as the latter affects metaphase 1 spermatocytes while preserving the normal morphology and localization of type A spermatogonial cells (Guardavaccaro et al. 2003) . To trace the possible cause of the phenotype divergence, we compared the mRNA expression levels of the two b-TrCP isoforms in different testicular cell types (Namekawa et al. 2006 ) versus a median pan-tissue expression (Lattin et al. 2008) . b-TrCP1 is expressed in spermatogonia at median expression levels (Fig. 1E , blue line and gray dot), yet is highly expressed in meiotic spermatocytes (Fig. 1E , blue line). Quite the opposite is the expression of b-TrCP2, with median levels in spermatogonial cells, but low expression (20% of the median) in meiotic cells (Fig. 1E , pink line and pink dot). Accordingly, b-TrCP1 knockout will not affect spermatogonia, only meiotic cells that rely on b-TrCP1 due to their low b-TrCP2 expression. KD2 alone will not have any testicular effect, since b-TrCP1 is preserved at sufficient functional levels (Fig. 1E , green triangle; Kudo et al. 2004 ) in all cell types. KO1/KD2 will then compromise total b-TrCP expression in spermatogonia to the extent that they cannot differentiate. Based on the distinct testicular phenotypes of b-TrCP1 knockout versus double-isoform b-TrCP ablation, it is tempting to speculate that one reason for the evolutionary conservation of two functional b-TrCP paralogs is in conjunction with regulation of male germ cell differentiation. Thus, b-TrCP1-specific modulation may adjust the pace of germ cell maturation without affecting spermatogonia-the germ lineage stem cells.
The testicular phenotype is reversible and is associated with impaired cell junctions
The testis is a highly dynamic tissue and has the capacity to restore itself once the cause of disorder is removed (Brinster 2002; Mruk et al. 2006) . To study the recovery potential of the KO1/KD2 testes, we took advantage of one unique characteristic of the shb-TrCP2 transgenic system-its reversibility-and compared the two testes of a KO1/KD2 mouse (n = 5) by harvesting them consecutively (Supplemental Fig. S2 ). Following a 4-wk tetracycline treatment, one testis was removed for analysis, tetracycline was discontinued, and, 4 wk later, the other testis was harvested. A nearly full reversion of the phenotype was observed, with repopulation of the seminiferous tubules by a full spectrum of the differentiating cells (Fig. 2 , top panel) and relocation of the spermatogonial cells to the periphery of the tubules (Fig. 2 , middle and bottom panels).
Spermatogenesis is associated with extensive cell junctions restructuring at the Sertoli-Sertoli cell and Sertoligerm cell interface (Yan et al. 2007 ). Considering the wellknown plasticity of the testicular cell junctions and plausible contribution of defective intercellular interactions to the observed phenotype, we studied the different cell junctions in the KO1/KD2 testes. As disruption of the Sertoli-germ cell adherens junctions does not affect the tight junction integrity (Xia et al. 2005b) , it was important to distinguish between damaged tight junctions (which maintain the blood-testis barrier) and adherens junctions (which control the trafficking of differentiating cells from the basal toward the luminal compartment) (Mruk et al. 2008) . The protein ZO-1 is localized primarily at tight junctions and in a subset of adherens junctions (the ectoplasmic specialization [ES] junctions between Sertoli and elongated spermatids) (Byers et al. 1991) . ZO-1 staining revealed the presence of intact tight junctions in KO1/ KD2 testes, whereas adherens junctions were absent ( Fig. 3A; Supplemental Fig. S3A ). In accord with this, E-cadherin, a key component of adherens junctions, was severely reduced in the KO1/KD2 testes (Fig. 3B) . Transmission electron microscopy of wild-type cells demonstrated long and close adhesions between Sertoli cells and neighboring primary spermatocytes with apparent association with cytoskeletal filaments, characteristic of adherens junctions, whereas no such junctions were observed in the KO1/KD2 testis, and their cell-to-cell adhesions were limited to short, intercellular adhesions (Supplemental Fig. S3B ). Upon tetracycline omission, both ZO-1 and E-cadherin reverted back to normal localization and expression levels (Fig. 3C) , supporting the notion that disruption of the adherens junctions plays a major role in the disordered structure of the KO1/KD2 testes. Snail1 stabilization accounts for the spermatogenesis defect E-cadherin levels are transcriptionally controlled by Snail1 (Cano et al. 2000) , a bona fide substrate of b-TrCP (Zhou et al. 2004 ). Snail1 immunostaining and Western blot analyses showed remarkable up-regulation of the protein levels in spermatogonoia of the KO1/KD2 mice (Fig. 4A,B, lanes 1,3,5,7) . To test whether Snail1 accumulation is responsible for the reduction of E-cadherin and impairment of the adherens junctions (Mruk et al. 2008 ), we depleted Snail1 in the testis by infecting one KO1/ KD2 testis (n = 7) with shRNA lentivirus targeting Snail1, while the other testis was infected with control shRNA. Both testes were harvested together, either 11 or 15 d post infection (Supplemental Fig. S4 ). The depletion of Snail1 was analyzed by Western blot (Fig. 4B ) and immunohistochemistry (Fig. 4C,D, middle panel) . Indeed, Snail1 depletion resulted in restoration of E-cadherin expression to nearly normal levels (Fig. 4C,D, bottom panels) . Remarkably, Snail1 knockdown virtually rescued the entire spermatogenesis defect of b-TrCP deficiency, evident by the overall organization of the seminiferous tubules 11 d post-infection (Fig. 4C, top panel) and the recovery of spermatogenesis at 15 d after Snail1 knockdown (Fig. 4D, top panel) . We conclude that the spermatogenesis defects following ablation of both b-TrCP isoforms were largely due to Snail1 stabilization, a most likely cause for the reduction of E-cadherin and impairment of adherens junctions. Notably, the spermatogenesis defect observed upon b-TrCP1 knockout only is presumably due to stabilization of a different substrate, Emi1 (Guardavaccaro et al. 2003) .
Discussion
The SCF (Skp1/Cullin/F-box protein) comprises a large subfamily of modular E3s-denoted Cullin Ring ubiquitin Ligase (CRL)-that control ubiquitination of many substrates, typically in a phosphorylation-dependent manner (Willems et al. 2004; Deshaies and Joazeiro 2009) . Only a minority of the SCF E3s has been assigned to established substrates, mostly regulators of the cell cycle and transcription, yet numerous studies have affirmed their important roles in controlling cell size, proliferation, and survival (Fuchs et al. 2004; Nakayama and Nakayama 2006) . Certain SCF E3s, such as SCF Skp2 and SCF b-TrCP , have been shown to promote tumorigenesis and could be considered as potential targets for anti-cancer therapy (Frescas and Pagano 2008) . To that end, a potent small molecule CRL inhibitor, targeting an essential Cullinmodifying enzyme (Nedd8 activation enzyme [NAE] ) has been developed recently and proved valuable in suppressing tumor growth (Soucy et al. 2009 ). Nevertheless, it is hard to predict the feasibility of systemic in vivo inhibition of the entire CRL E3 family, or even a single CRL like SCF
b-TrCP
, which controls the turnover of multiple essential cellular proteins. We learned that very high-level systemic inhibition of b-TrCP is compatible with the well-being of treated mice, indicating a considerable robustness of physiologic cellular protein turnover. This feature likely depends on the small residual activity of b-TrCP2, rather than other compensatory mechanisms. Our preliminary studies of another tissue (the mouse gut) indicate that, whereas 20% b-TrCP2 expression on a b-TrCP1-null background (Supplemental Fig. S1C ) is compatible with normal tissue homeostasis, complete ablation of both b-TrCP isoforms in the same tissue is fatal. Conceivably, cancer cells, in contrast to normal cells, are far more vulnerable to deregulation of protein turnover (Adams 2004) ; an example is multiple myeloma cells succumbing to partial intermittent proteasomal inhibition (LeBlanc et al. 2002) . However, our study of the testis indicates that this distinction between normal and malignant cells may not always hold true. If a system relies on dynamic protein turnover, as necessary for continuously remodeling adherens junctions in the renewing testis, deregulating a single key component of this process, like Snail1, may greatly compromise homeostasis (Perez-Moreno et al. 2003) . On the other hand, the testis is an example of a tissue having a remarkable plasticity that is capable of restoring its normal architecture and function shortly after terminating the SCF b-TrCP inhibition. Cold
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Should this property characterize other rapidly renewing adult tissues, temporary SCF b-TrCP inhibition may be systemically tolerable, providing means of specifically affecting tumor cells, and could even be harnessed for other medical benefits, such as developing male contraceptives.
Materials and methods
shRNA lentiviral vectors targeting b-TrCP and Snail1
The shRNA lentiviral vector was constructed by inserting an XmaI-NotI fragment from pEGFP-N1 (Clontech) and the hEF1a promoter into the pcDNA6/TR plasmid (Invitrogen) at the EcoRI and SpeI-HindIII sites, respectively. The hEF1a promoter-Tet Repressor-GFP cassette was then excised with BglII and inserted into a lentiviral backbone vector (Zufferey et al. 1998) at the PstI and MscI sites. The b-TrCP targeting shRNA cassette was generated using the pTER system (van de Wetering et al. 2003) , cut by EcoRI, and inserted to the lentiviral backbone plasmid at the EcoRV site. Plasmids encoding shRNA targeting mouse Snail were purchased from Open BioSystems. shRNA sequences were as follows: b-TrCP2 shRNA, GGACTTGTGCATTAAGTAC; Snail1 shRNA, GCCCAACTATAGCGAGCTGCA.
Lentivirus production
High-titer lentiviral vectors were generated by transfecting 10 14-cm plates of HEK 293T cells with the lentiviral backbone along with the packaging plasmids (gag-pol and pMD.G) using the BBS/calcium phosphate transfection reagent (50 mM BES, 280 mM NaCl, 1.5 mM Na 2 HPO 4 at pH 6.95, 0.25 M CaCl 2 ). Supernatant was centrifuged in an ultracentrifuge (Beckman Coulter Avanti, J-30I). The pellet was resuspended in 200 mL of KSOM transgene buffer (Chemicon).
Generation of transgenic mice
Generation of transgenic mice using lentivirus transduction was performed as described (Lois et al. 2002; Singer et al. 2006) . In brief, the concentrated virus was injected into the perivitelline space of C57Bl6/F1 zygotes. Following a 3-d incubation period, the developed blastocytes were checked for expression of GFP using confocal microscopy, and were transferred into pseudopregnant foster mothers. Adult founder mice were bred with C57Bl/6 mice (Harlan Laboratories).
Production of MEFs
MEFs were prepared from 12.5-d-post-coitum embryos and seeded onto 10-cm plates precoated with 0.5% gelatin. Culture was maintained in Dulbeco's modified Eagle's medium (GIBCO) supplemented with 10% fetal calf serum (Beit Haemek).
RNA and protein extraction, quantitative PCR (qPCR) analyses
RNA was recovered from tissues using Sigma Tri-Reagent according to the manufacturer's instructions. cDNA was prepared using Snail1 depletion rescues a b-TrCP-deficient mouse MMLV Reverse Transcriptase (Invitrogen). Quantitative real-time PCR analysis was performed using the Platinum SYBR green reagent (Invitrogen) and an ABI prism 7900 real-time thermocycler. Protein extracts were prepared in protein lysis buffer (50 mM Tris, 420 mM NaCl, 5 mM EDTA) supplemented with protease and phosphatase inhibitors.
Antibodies and immunohistochemistry
The following antibodies were used: phosphorylated b-catenin (Ser33, Ser37, and Thr41), phosphorylated IkBa (Ser36), b-catenin (Cell Signaling), IkBa (Santa Cruz Biotechnologies), E-cadherin (BD Transduction Laboratories), phospho-Histone H3 (Upstate Biotechnologies), Snail1 (Abcam), ZO-1 (Zymed), Oct3/4 rabbit antisera (Gidekel et al. 2003) . Immunohistochemical analyses were performed using standard procedures. Antigens were retrieved from either formaldehyde or bouin-fixed paraffin-embedded 5-mm sections in a decloaking chamber (Biocare Medical) in 20 mM Citrate buffer (pH 6). Antibodies were hybridized in CAS-BLOCK (Zymed). HRP-conjugated secondary antibodies were goat anti-rabbit (Nichirei Bioscience) and goat anti-mouse (Dako). Chromogen substrate for HRP reaction was DAB plus (Thermo Scientific). Fluorescent secondary antibodies were Alexa 488 or Alexa 647 goat Ig conjugates (Invitrogen). 
Animal procedures
All procedures were approved by the Animal Care and Use Committee of the Hebrew University of Jerusalem. Animals were provided food and water ad libitum. Removal of the testis was performed as follows: Mice were anesthetized with Ketamin-Xylasine (200 mg/kg and 10 mg/kg, respectively). The skin around the testis area was incised and one testis was exposed. Removal of the testis was performed by cutting the testis and tying the blood vessels with a polyamide string. Lentiviral transduction of the testis was performed by anesthetizing the mice and injecting 25 mL of concentrated virus into the testis capsule. Following each surgical procedure, wounds were sutured with a polyamide string, and mice were subcutaneously injected with 100 mg of Rimadyl (Pfizer) in 1 mL of sterile PBS.
Transmission electron microscopy
Animals were sacrificed as described and testes were removed and immediately fixed by Karnovsky's fixative. Following CaCodylate buffer washes and post-fixation with 2% OSO 4 , samples were dehydrated in ethanol gradient and transferred into propylen oxide. Embedding was done in beam capsules by EMbed 812 Resin (EMS no. 14120) for 48 h at 60°C. Thin sections (50-70 nm) were stained by uranyl acetate and lead citrate and were examined under a Philips EM 12P (voltage, 100 kV) electron microscope.
